Florida paramedic accused of stealing coronavirus vaccines orlandosentinel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orlandosentinel.com Daily Mail and Mail on Sunday newspapers.
Really good news : Federal defense bill could move UNMC NExT project forward
Multi-billion dollar expansion would bring federal disaster response facility to the campus Share Updated: 10:29 PM CST Jan 17, 2021
Multi-billion dollar expansion would bring federal disaster response facility to the campus Share Updated: 10:29 PM CST Jan 17, 2021
Hide Transcript
Show Transcript FORWARD. ALEXANDRA: IMAGINE THIS CORNER OF THE UNMC CAMPUS TRANSFORMED, TWO AND A HALF MILLION SQUARE FEET OF NEW CONSTRUCTION RISING ABOVE FARNAM AND SADDLE CREEK. IT IS A TRANSFORMATION FOR OUR REGION, FOR OUR STATE. ALEXANDRA: THE NEXT PROJECT IS MEANT TO BE PART OF NETWORK OF FACILITIES ACROSS THE COUNTRY EQUIPPED FOR LARGE SCALE DISASTER RESPONSE. UNMC CHANCELLOR DR. JEFFREY GOLD SAYS THAT’S EVERYTHING FROM HURRICANES AND TORNADOES TO CHEMICAL SPILLS, NUCLEAR ACCIDENTS AND INFECTIOUS DISEASES. SOMEWHERE BETWEEN FIVE AND 15 DEDICATED CENTERS THAT COULD EXPAND AND CO
First published on
With two highly effective coronavirus vaccines now being distributed across the country, the U.S. government’s announcement Thursday to set aside $2.6 billion for purchasing an antibody drug for COVID-19 may have raised a few eyebrows.
After all, the two currently authorized antibody drugs, from Regeneron and Eli Lilly, have not been widely used since the Food and Drug Administration cleared both in November. And the logistical issues that have hindered their launch haven’t been solved, either.
But Operation Warp Speed officials, including top FDA drug evaluator Janet Woodcock, are campaigning hard to change that, arguing the drugs are being “underutilized” in the COVID-19 response. Study results have shown the treatments can keep some sick patients from needing hospital care, which could be a huge benefit for healthcare systems under greater and greater strain.
HHS, TMC launch monoclonal antibody treatment center for COVID-19 patients (Source: kold) By KOLD News 13 Staff | January 7, 2021 at 11:06 AM MST - Updated January 8 at 11:44 AM
TUCSON, Ariz. (KOLD News 13) - The U.S. Department of Health and Human Services (HHS) and Tucson Medical Center (TMC) today began administering monoclonal antibody therapeutic treatments at a temporary COVID-19 infusion center in Tucson.
The center is the second federally supported infusion center in the country to treat certain COVID-19 patients in order to prevent hospitalization and the severity of illness. The TMC antibody infusion center will treat patients with mild to moderate symptoms who have tested positive for COVID-19 and are at high risk of severe illness or hospitalization. Patients at the infusion center will receive one of two monoclonal antibody therapeutics authorized by the U.S. Food and Drug Administration (FDA), either one from Eli Lilly and Co., which uses the monoclonal antib
EL CENTRO â El Centro Regional Medical Center is hopeful a new therapy for treating high-risk COVID-19 patients will limit the number of hospital admissions, improve patient outcomes and reduce strain on the hospitalâs resources.
The U.S. Department of Health and Human Services opened a temporary infusion center on the south side of the hospital Wednesday to begin administering monoclonal antibody therapeutic treatments.
The center is the first in a pilot program to treat certain COVID-19 patients in order to prevent hospitalization and the severity of illness.
Monoclonal antibodies are antibodies created in a laboratory. They act similarly to natural antibodies to limit the amount of virus in the body.